INS and fatty liver disease: Peripheral injection of FGF1 in diabetic HFD-fed mice and ob/ob mice restored normoglycemia, improved insulin sensitivity, reduced hepatic steatosis and inflammation, independent of weight loss, and without inducing hypoglycemia [30].